Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 19/20 | 0.66 |
| ▸ | NPY1R | P25929 | 12/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.66 |
| ▸ | NPY2R | P49146 | 8/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31256955 | 0.99 | NPY4R (0.68) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29679844 | 0.95 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30420887 | 0.93 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30331308 | 0.92 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL5598812 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31184322 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL5598820 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31184376 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13563452 | 0.91 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL2815459 | 0.91 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | MC4R, MC3R, MC5R | NPY4R 6/4885NPY1R 9/4885NPY5R 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.